MVZ im Altstadt-Carree Fulda GmbH

The General Physician department at MVZ im Altstadt‑Carree Fulda GmbH conducts research aimed at preventing heart attacks, strokes, and heart failure in adults at high cardiovascular risk.

• Prevention of heart failure in high‑risk populations
• Evaluation of novel lipid‑lowering agents
• Assessment of therapies for heart failure with preserved ejection fraction
• Investigation of treatments that reduce major adverse cardiovascular events
• Exploration of combined approaches for obesity‑related cardiac risk

These studies reinforce the site’s dedication to improving cardiovascular health in the community.

Research in the digestive field targets functional bowel disorders and chronic constipation, seeking safer and more effective symptom relief for patients.

• Oral probiotic therapy for diarrhoea‑predominant irritable bowel syndrome
• Long‑term safety of laxative treatment for chronic constipation
• Impact of gut‑focused interventions on quality of life
• Dietary strategies to manage functional bowel symptoms

The program highlights the clinic’s commitment to advancing digestive health care.

Studies explore the role of inflammation in cardiovascular and metabolic conditions, evaluating agents that modulate the immune response.

• Targeting inflammatory pathways in heart failure
• Anti‑inflammatory therapies for patients with high cardiovascular risk
• Immune modulation strategies in metabolic disease management

This work supports a growing interest in linking immune health to chronic disease outcomes.

The site focuses on interventions for type 2 diabetes, obesity, and related metabolic disorders, aiming to improve glycaemic control and reduce cardiovascular complications.

• Weight‑loss programs combined with diabetes management
• Comparative effectiveness of weekly versus daily insulin regimens
• New glucose‑lowering agents and their impact on heart health
• Therapies addressing hyperlipidaemia and metabolic syndrome

These initiatives reflect a comprehensive approach to metabolic health in the Fulda region.

Clinical work includes evaluating symptomatic treatments for acute pharyngitis, aiming to provide rapid relief while ensuring safety.

• Lozenges containing benzydamine for sore throat relief
• Non‑invasive options for managing throat inflammation
• Comparison of active comparators and placebo in pharyngitis symptom control

The research contributes to better outpatient care for common ENT complaints.